Last May, Hims & Hers soared after a blue-chip GLP-1 shortage allowed the firm to start making its own knockoff semaglutide
Overall, its really beneficial for appetite suppression and blood sugar control and, ultimately, weight loss. Semaglutide was developed by Novo Nordisk and received FDA approval in December 2017 under the name Ozempic as a Type 2 diabetes treatment
Improve Mood and Mental Clarity : A healthy gut can positively influence mental well-being
CagriSema has been developed as an improvement on Novos weight loss powerhouse semaglutide, a GLP-1 receptor agonist marketed as Ozempic for type 2 diabetes and Wegovy for obesity
The World Health Organization warned that counterfeit Ibrance, which treats advanced breast cancer, had been found in Cote dIvoire, Egypt, Lebanon, Libya, and Turkey in November 2025
Use up-to-date cost-effectiveness analysis : Coverage decisions must incorporate the latest data on the clinical benefits of GLP-1s